Support FDA’s additive reviews, petitions, and rulemakings to revoke or restrict high-risk dyes and accelerate approval of safer natural alternatives.
Help FDA turn the current attention on synthetic dyes into durable, enforceable national standards. This strategy supports additive reviews, petitions, and rulemakings that revoke or restrict high-risk dyes and clarify what manufacturers must do next. The goal is a predictable federal baseline that reduces the need for a patchwork of state and school rules.
Why this works
- National impact; creates a single standard that manufacturers can build around.
Public Citizen
AdvocacyChampioning consumer rights and accountable government
Mechanism
About LobbyingHow Public Citizen uses funding
- Identify the highest-impact FDA actions already in motion and the decision points that control timelines.
- Submit and support petitions, comments, and evidence that strengthen the administrative record for revocations or restrictions.
- Brief policymakers and agency leadership to keep prioritization and resourcing aligned with public health goals.
- Coordinate with public health advocates to sustain pressure and respond to industry arguments.
- Push for clear, usable standards and guidance so compliance is predictable for manufacturers.
- Track progress and communicate milestones so momentum is sustained through final decisions.
Milestones
Checkpoints and the expected timing for each step
- 1
FDA docket and evidence package assembled
EarlyPriority actions, supporting evidence, and stakeholder narratives are organized for effective participation.
- 2
Comments and petitions strengthened
During review and rulemakingThe record includes clear support for revocations, restrictions, and a national standard.
- 3
Draft standard and guidance clarified
As FDA actsStakeholders can point to clear expectations and a coherent pathway for compliance.
- 4
Final federal actions issued
At decision pointA final revocation, restriction, or national standard is published and enforceable.
- 5
Implementation tracked
After issuanceProgress is monitored and barriers (like supply constraints) are documented for follow-on fixes.